AstraZeneca vaccine as third dose effective against Omicron: Study

The results were observed among individuals previously vaccinated with either Vaxzevria or an mRNA vaccine.

published on : 13th January 2022

Serum Institute applies to Indian authorities for full market authorisation of Covishield

SII had partnered with the developer of Covishield, AstraZeneca, for the supply of the vaccine to the Indian government, which had in January this year granted emergency use authorisation.

published on : 31st December 2021

Asia keeps omicron at bay, but a surge may be inevitable

Countries such as Japan, South Korea, China and Thailand quickly reinstated entry and quarantine restrictions in recent weeks after relaxing them in the fall. 

published on : 29th December 2021

Oxford/AstraZeneca vaccine behind lower COVID deaths in UK, says expert

According to Our World in Data, a website run by the University of Oxford, the UK has 1.7 daily deaths from COVID per million people.

published on : 27th December 2021

Third dose of Covishield significantly boosts antibodies against Omicron: Study

The study found that antibody levels against Omicron after the booster shot were higher than antibodies in people who had been infected with and recovered naturally from Covid-19.  

published on : 23rd December 2021

AstraZeneca Covid vaccine protection wanes after three months: Lancet study

Researchers analysed data for two million people in Scotland and 42 million people in Brazil who had been vaccinated with the AstraZeneca vaccine.

published on : 22nd December 2021

AstraZeneca’s Evusheld therapy may be effective against Omicron: Study

Evusheld has also received authorisations in other countries, the pharma major said, adding that it is now working with regulators on applications for the use of Evusheld in treating Covid.

published on : 18th December 2021

USFDA study shows Evusheld retains neutralising activity against Omicron: AstraZeneca

Evusheld is a long-acting antibody combination for the prevention of COVID-19.

published on : 17th December 2021

Amid vaccine alliance chief's warning, Israel to assist inoculation drive at African nations

The Foreign Ministry said the AstraZeneca vaccines would be transferred in the coming weeks, a decision that was part of Israel's strengthening ties with the African countries.

published on : 16th December 2021

Next virus could be more lethal, warns Oxford University COVID vaccine creator

Gilbert, who was made a Dame by Queen Elizabeth II for her pivotal role in developing the Oxford/AstraZeneca vaccine, said there needed to be more funding for pandemic preparedness.

published on : 7th December 2021

Next virus to hit humankind could be more lethal, warns Oxford-AstraZeneca vaccine creator

Speaking about the Omicron variant of the novel coronavirus, she said its spike protein contained mutations known to increase the transmissibility of the virus.

published on : 6th December 2021

AstraZeneca opens research centre as UK builds science hub

The 19,000 square-meter (more than 200,000 square-foot) complex will house more than 2,200 research scientists.

published on : 23rd November 2021

AstraZeneca set for 'modest' profit from sold COVID-19 vaccines

The Oxford/AstraZeneca vaccine, which is also being manufactured by the Serum Institute of India (SII) as part of an agreement, has until now been sold on a not-for-profit basis.

published on : 13th November 2021

US to allow international visitors, here are the new travel rules

The new rules allow air travel from previously restricted countries as long as the traveller has proof of being jabbed with any WHO-recognized vaccine and a negative COVID-19 test. 

published on : 8th November 2021

AstraZeneca withdraws request for Swiss approval of universal COVID shot

Switzerland has cleared the BioNTech-Pfizer, Moderna and Johnson & Johnson vaccines for use.

published on : 5th November 2021
1 2 3 4 5 >